10 insiders reported 14 Form 4 transactions for Evoke Pharma Inc (EVOK) over the past 18 months (most recent 2025-12-19). Recent activity: Nantahala Capital Management, LLC (Insider) Sell 148,153 shares, Mack Daniel (Insider) Sell 148,153 shares, Harkey Wilmot B. (Insider) Sell 148,153 shares, CARLSON MARILYN R. (Chief Medical Officer) Sell 360 shares, GARNER CAM L (Director) Sell 2,330 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-19 | Nantahala Capital Management, LLC | Insider | Sell | 148,153 | $1.6M |
| 2025-12-19 | Mack Daniel | Insider | Sell | 148,153 | $1.6M |
| 2025-12-19 | Harkey Wilmot B. | Insider | Sell | 148,153 | $1.6M |
| 2025-12-17 | CARLSON MARILYN R. | Chief Medical Officer | Sell | 360 | $0 |
| 2025-12-17 | GARNER CAM L | Director | Sell | 2,330 | $0 |
| 2025-12-17 | Kowieski Mark | Chief Financial Officer | Sell | 11,815 | $0 |
| 2025-12-17 | D'Onofrio Matthew J | Chief Executive Officer | Sell | 15,509 | $0 |
| 2025-12-17 | Hill Malcolm R | Director | Sell | 133 | $0 |
| 2025-12-17 | Brady Todd C | Director | Sell | 27 | $0 |
| 2025-11-07 | Klein Roger M. | Insider | Sell | 5,000 | $53,300 |
| 2025-11-07 | Klein Roger M. | Insider | Sell | 4,000 | $42,600 |
| 2025-03-24 | D'Onofrio Matthew J | Chief Executive Officer | Buy | 1,000 | $2,800 |
| 2025-03-24 | Kowieski Mark | Chief Financial Officer | Buy | 4,500 | $14,445 |
| 2025-03-03 | D'Onofrio Matthew J | Chief Executive Officer | Buy | 6,849 | $24,999 |
Source: SEC Form 4 filings · as of 2025-12-19